Startups
RealizedCare
United States
RealizedCare is the acquired immersive digital-therapeutics business built around BehaVR, OxfordVR and Fern Health. Its products combine virtual reality, cognitive behavioral approaches and biopsychosocial care for chronic pain and behavioral-health conditions, with AI-supported care triage described by its acquirer. Historical BehaVR was founded in 2016 and filed as BehaVR LLC, later BehaVR Inc. OxfordVR combined with BehaVR alongside a USD13M Series B in December 2022; Fern Health joined the platform under the RealizedCare brand in 2023. These historical issuer and acquisition boundaries are qualified rather than treated as interchangeable independent funding recipients. XRHealth announced the acquisition in February 2025 and appointed founder Aaron Gani general manager of XRHealth US. A September2026 buyer SEC filing identifies the seller as BehaVR Holdings Inc. (RealizedCare) and reports stock consideration for an asset purchase. That noncash transaction and a separately filed XRHealth loan are not represented as new RealizedCare financing. Current standalone leadership could not be verified from the inaccessible current company site; attached public leadership and scientific advisory affiliations are expressly historical or source-dated. Verified financing includes a partial USD500K debt securities sale disclosed in2018, an adviser-confirmed completed USD10M2020SeriesA (with an earlier partial SEC disclosure qualified), and an actual USD13M2022SeriesB. Funding targets, undisclosed additional financing reported retrospectively, contingent licensing payments and academic research budgets are not added as cash raised. OxfordVR’s separate precombination capital history remains a distinct issuer research task. The 2021 Sumitomo digital-therapeutics licensing programme is qualified as a commercial development arrangement. FDA Breakthrough Device designation for OxfordVR technology is not FDA marketing approval.
Team
 Aaron GaniFounder and CEO (historical BehaVR/RealizedCare; before 2025 acquisition) · Director (historical BehaVR; SEC 2020 filing) |
 Adriaan LouwScientific Advisory Board (historical; published October 2021) |
 Amelia AldaoScientific Advisory Board (historical; published October 2021) |
 Bill FristDirector (historical BehaVR; SEC 2020 filing) |
 Daniel FreemanScientific Founder of OxfordVR; combined-company scientific leadership (historical 2022) |
Erin ConwellDirector of Marketing (historical Fern Health/RealizedCare) |
 Hunter HoffmanScientific Advisory Board (historical; published October 2021) |
 Jillian AhrensChief Product and Design Officer (historical RealizedCare) |
 M. Zachary RosenthalScientific Advisory Board (historical; published October 2021) |
 Patrick MurtaChief Technology Officer (historical RealizedCare) |
 Risa WeisbergChief Clinical and Scientific Officer (historical RealizedCare) |
 Rory ChannerChief Commercial Officer (historical; appointment announced January 2021) |
 Takehiko NomuraDirector (historical BehaVR; SEC 2020 filing) |
 Walter GreenleafScientific Advisory Board (historical; published October 2021) |